PLEASANTON, Calif., Jan. 03, 2017 -- Natus Medical Incorporated (NASDAQ:BABY) today announced that it has completed the acquisition of GN Otometrics from GN Store Nord A/S (GN.CO) that was announced on September 26, 2016. Based in Taastrup, Denmark, Otometrics provides hearing screening, hearing diagnostic and balance care tools and software to hospitals and professional worldwide.
About Otometrics
Otometrics is a leader in the hearing and balance assessment market. Otometrics provides computer-based audiological, otoneurologic and vestibular instrumentation and sound rooms to hearing and balance care professionals worldwide. Otometrics has a complete product and brand portfolio known for its sophisticated design technology in the hearing and balance assessment markets. Global brands include Aurical®, ICS® and Madsen®.
Additional information about GN Otometrics can be found at www.otometrics.com.
About Natus Medical Incorporated
Natus is a leading provider of healthcare products and services used in the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders.
Additional information about Natus Medical can be found at www.natus.com.
COMPANY CONTACT: Natus Medical Incorporated Jonathan A. Kennedy Executive Vice President Finance and Chief Financial Officer (925) 223-6700 [email protected]


Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
Bank of America's $72.5M Epstein Settlement: What You Need to Know
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Brown-Forman and Pernod Ricard in Merger Talks to Create World's Largest Spirits Giant
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Unilever and Magnum Face Defamation Lawsuit Over Ben & Jerry's Board Chair Dismissal 



